386 related articles for article (PubMed ID: 10526188)
1. Serum antibody against a peripheral nerve myelin ganglioside, LM1, in Guillain-Barré syndrome.
Yako K; Kusunoki S; Kanazawa I
J Neurol Sci; 1999 Oct; 168(2):85-9. PubMed ID: 10526188
[TBL] [Abstract][Full Text] [Related]
2. Antibodies to LM1 and LM1-containing ganglioside complexes in Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy.
Kuwahara M; Suzuki S; Takada K; Kusunoki S
J Neuroimmunol; 2011 Oct; 239(1-2):87-90. PubMed ID: 21914557
[TBL] [Abstract][Full Text] [Related]
3. [Antiganglioside antibodies: when, which and for what].
Gallardo E; Rojas-García R; Belvís R; Serrano-Munuera C; Ortiz E; Ortiz N; Grau J; Illa I
Neurologia; 2001; 16(7):293-7. PubMed ID: 11485721
[TBL] [Abstract][Full Text] [Related]
4. Anti-LM1 antibodies in the sera of patients with Guillain-Barré syndrome, Miller Fisher syndrome, and motor neuron disease.
Harukawa H; Utsumi H; Asano A; Yoshino H
J Peripher Nerv Syst; 2002 Mar; 7(1):54-8. PubMed ID: 11939352
[TBL] [Abstract][Full Text] [Related]
5. Distinct immunoglobulin class and immunoglobulin G subclass patterns against ganglioside GQ1b in Miller Fisher syndrome following different types of infection.
Schwerer B; Neisser A; Bernheimer H
Infect Immun; 1999 May; 67(5):2414-20. PubMed ID: 10225903
[TBL] [Abstract][Full Text] [Related]
6. [Antiganglioside autoantibody profiles in Guillain-Barré syndrome].
Caudie C; Vial C; Bancel J; Petiot P; Antoine JC; Gonnaud PM
Ann Biol Clin (Paris); 2002; 60(5):589-97. PubMed ID: 12368145
[TBL] [Abstract][Full Text] [Related]
7. Clinical relevance of serum antibodies to GD1b in immune-mediated neuropathies.
Taams NE; Notermans NC; Fokkink WR; Tio-Gillen AP; Huizinga R; Schreurs MWJ; Jacobs BC
J Peripher Nerv Syst; 2018 Dec; 23(4):227-234. PubMed ID: 30101437
[TBL] [Abstract][Full Text] [Related]
8. Antibodies in sera from patients with inflammatory demyelinating polyradiculoneuropathy react with ganglioside LM1 and sulphatide of peripheral nerve myelin.
Fredman P; Vedeler CA; Nyland H; Aarli JA; Svennerholm L
J Neurol; 1991 Apr; 238(2):75-9. PubMed ID: 1856740
[TBL] [Abstract][Full Text] [Related]
9. Molecular mimicry between gangliosides and lipopolysaccharides of Campylobacter jejuni isolated from patients with Guillain-Barré syndrome and Miller Fisher syndrome.
Yuki N
J Infect Dis; 1997 Dec; 176 Suppl 2():S150-3. PubMed ID: 9396700
[TBL] [Abstract][Full Text] [Related]
10. Close association of IgA anti-ganglioside antibodies with antecedent Campylobacter jejuni infection in Guillain-Barré and Fisher's syndromes.
Koga M; Yuki N; Takahashi M; Saito K; Hirata K
J Neuroimmunol; 1998 Jan; 81(1-2):138-43. PubMed ID: 9521615
[TBL] [Abstract][Full Text] [Related]
11. Fine specificities of anti-LM1 IgG antibodies in Guillain-Barré syndrome.
Susuki K; Yuki N; Hirata K; Kuwabara S
J Neurol Sci; 2002 Mar; 195(2):145-8. PubMed ID: 11897245
[TBL] [Abstract][Full Text] [Related]
12. [Measurement of antiganglioside autoantibodies by immunodot-blot assay: clinical importance in peripheral neuropathies].
Caudie C; Vial C; Petiot P; Bancel J; Later R; Gonnaud PM
Ann Biol Clin (Paris); 1999; 57(5):579-88. PubMed ID: 10518060
[TBL] [Abstract][Full Text] [Related]
13. Clinical presentation and outcome of Guillain-Barré and related syndromes in relation to anti-ganglioside antibodies.
Carpo M; Pedotti R; Allaria S; Lolli F; Matà S; Cavaletti G; Protti A; Pomati S; Scarlato G; Nobile-Orazio E
J Neurol Sci; 1999 Oct; 168(2):78-84. PubMed ID: 10526187
[TBL] [Abstract][Full Text] [Related]
14. Preceding infections and anti-ganglioside antibody profiles assessed by a dot immunoassay in 306 French Guillain-Barré syndrome patients.
Caudie C; Quittard Pinon A; Taravel D; Sivadon-Tardy V; Orlikowski D; Rozenberg F; Sharshar T; Raphaël JC; Gaillard JL
J Neurol; 2011 Nov; 258(11):1958-64. PubMed ID: 21516465
[TBL] [Abstract][Full Text] [Related]
15. Detection of anti-ganglioside antibodies in Guillain-Barré syndrome and its variants by the agglutination assay.
Alaedini A; Briani C; Wirguin I; Siciliano G; D'Avino C; Latov N
J Neurol Sci; 2002 Apr; 196(1-2):41-4. PubMed ID: 11959155
[TBL] [Abstract][Full Text] [Related]
16. Analysis of humoral immune responses to LM1 ganglioside in guinea pigs.
Gu Y; Chen ZW; Siegel A; Koshy R; Ramirez C; Raabe TD; Devries GH; Ilyas AA
J Neuroimmunol; 2012 May; 246(1-2):58-64. PubMed ID: 22464399
[TBL] [Abstract][Full Text] [Related]
17. Autoantibodies to peripheral nerve glycosphingolipids SPG, SLPG, and SGPG in Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy.
Yuki N; Tagawa Y; Handa S
J Neuroimmunol; 1996 Oct; 70(1):1-6. PubMed ID: 8862128
[TBL] [Abstract][Full Text] [Related]
18. Longitudinal changes of anti-ganglioside antibodies before and after Guillain-Barré syndrome onset subsequent to Campylobacter jejuni enteritis.
Odaka M; Koga M; Yuki N; Susuki K; Hirata K
J Neurol Sci; 2003 Jun; 210(1-2):99-103. PubMed ID: 12736097
[TBL] [Abstract][Full Text] [Related]
19. Pathogenesis of Guillain-Barré and Miller Fisher syndromes subsequent to Campylobacter jejuni enteritis.
Yuki N
Jpn J Infect Dis; 1999 Jun; 52(3):99-105. PubMed ID: 10507987
[TBL] [Abstract][Full Text] [Related]
20. Guillain Barré Syndrome is induced in Non-Obese Diabetic (NOD) mice following Campylobacter jejuni infection and is exacerbated by antibiotics.
St Charles JL; Bell JA; Gadsden BJ; Malik A; Cooke H; Van de Grift LK; Kim HY; Smith EJ; Mansfield LS
J Autoimmun; 2017 Feb; 77():11-38. PubMed ID: 27939129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
